Primitigravir, also known as GS-9131, is an investigational antiretroviral drug being developed for the treatment of HIV-1 infection. It belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). These drugs work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV. By blocking this enzyme, primitigravir helps … Continue reading Primitigravir (GS-9131) for HIV – Overview